Switch theme
Sign up to access all valuation multiples
Lepu Medical Technology (Beijing) Co Ltd is a China-based company. It specializes in developing, manufacturing, and marketing high-tech medical devices and equipment. The company is engaged in the fields of cardiovascular interventions, structural heart diseases, cardiac rhythm management, anesthesia, and critical care, in vitro diagnostics and general surgery.
2008
510
LTM Revenue $890M
LTM EBITDA $194M
$3.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Lepu Medical Technology has a last 12-month revenue (LTM) of $890M and a last 12-month EBITDA of $194M.
In the most recent fiscal year, Lepu Medical Technology achieved revenue of $847M and an EBITDA of $134M.
Lepu Medical Technology expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Lepu Medical Technology valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $890M | XXX | $847M | XXX | XXX | XXX |
| Gross Profit | $546M | XXX | $516M | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 61% | XXX | XXX | XXX |
| EBITDA | $194M | XXX | $134M | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 16% | XXX | XXX | XXX |
| EBIT | $93.4M | XXX | $99.5M | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 12% | XXX | XXX | XXX |
| Net Profit | $76.7M | XXX | $34.3M | XXX | XXX | XXX |
| Net Margin | 9% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $28.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Lepu Medical Technology's stock price is CNY 12 (or $2).
Lepu Medical Technology has current market cap of CNY 21.6B (or $3.0B), and EV of CNY 23.4B (or $3.3B).
See Lepu Medical Technology trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.3B | $3.0B | XXX | XXX | XXX | XXX | $0.04 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Lepu Medical Technology has market cap of $3.0B and EV of $3.3B.
Lepu Medical Technology's trades at 3.8x EV/Revenue multiple, and 24.2x EV/EBITDA.
Equity research analysts estimate Lepu Medical Technology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Lepu Medical Technology has a P/E ratio of 39.1x.
See valuation multiples for Lepu Medical Technology and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3.0B | XXX | $3.0B | XXX | XXX | XXX |
| EV (current) | $3.3B | XXX | $3.3B | XXX | XXX | XXX |
| EV/Revenue | 3.7x | XXX | 3.8x | XXX | XXX | XXX |
| EV/EBITDA | 16.8x | XXX | 24.2x | XXX | XXX | XXX |
| EV/EBIT | 34.8x | XXX | 32.7x | XXX | XXX | XXX |
| EV/Gross Profit | 6.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | 39.1x | XXX | 87.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 309.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialLepu Medical Technology's last 12 month revenue growth is 12%
Lepu Medical Technology's revenue per employee in the last FY averaged $1.7M, while opex per employee averaged $0.8M for the same period.
Lepu Medical Technology's rule of 40 is 40% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Lepu Medical Technology's rule of X is 51% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Lepu Medical Technology and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 41% | XXX | -8% | XXX | XXX | XXX |
| Rule of 40 | 40% | XXX | 28% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 51% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.7M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.8M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 12% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 13% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 49% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lepu Medical Technology acquired XXX companies to date.
Last acquisition by Lepu Medical Technology was XXXXXXXX, XXXXX XXXXX XXXXXX . Lepu Medical Technology acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Lepu Medical Technology founded? | Lepu Medical Technology was founded in 2008. |
| Where is Lepu Medical Technology headquartered? | Lepu Medical Technology is headquartered in China. |
| How many employees does Lepu Medical Technology have? | As of today, Lepu Medical Technology has 510 employees. |
| Is Lepu Medical Technology publicy listed? | Yes, Lepu Medical Technology is a public company listed on SHE. |
| What is the stock symbol of Lepu Medical Technology? | Lepu Medical Technology trades under 300003 ticker. |
| When did Lepu Medical Technology go public? | Lepu Medical Technology went public in 2009. |
| Who are competitors of Lepu Medical Technology? | Similar companies to Lepu Medical Technology include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Lepu Medical Technology? | Lepu Medical Technology's current market cap is $3.0B |
| What is the current revenue of Lepu Medical Technology? | Lepu Medical Technology's last 12 months revenue is $890M. |
| What is the current revenue growth of Lepu Medical Technology? | Lepu Medical Technology revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Lepu Medical Technology? | Current revenue multiple of Lepu Medical Technology is 3.7x. |
| Is Lepu Medical Technology profitable? | Yes, Lepu Medical Technology is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Lepu Medical Technology? | Lepu Medical Technology's last 12 months EBITDA is $194M. |
| What is Lepu Medical Technology's EBITDA margin? | Lepu Medical Technology's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Lepu Medical Technology? | Current EBITDA multiple of Lepu Medical Technology is 16.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
